Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mar Guasp

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Brain : a Journal of Neurology|July 15, 2023
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studiesThaís Armangué, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, et al.
The Lancet. Neurology|December 20, 2024
Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysisGemma Olivé-Cirera, Elianet Fonseca, Li-Wen Chen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Annals of Neurology|April 13, 2026
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABA<sub>A</sub> Receptor EncephalitisClaudia Papi, Chiara Milano, Laura Marmolejo, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 DiseaseYvette S Crijnen, Verena Endmayr, Suzanne C Franken, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
The Lancet. Neurology|March 21, 2026
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort studyMar Guasp, Mateus Mistieri Simabukuro, Guillermo Muñoz-Sánchez, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Brain : a Journal of Neurology|July 15, 2023
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studiesThaís Armangué, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, et al.
The Lancet. Neurology|December 20, 2024
Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysisGemma Olivé-Cirera, Elianet Fonseca, Li-Wen Chen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Annals of Neurology|April 13, 2026
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABA<sub>A</sub> Receptor EncephalitisClaudia Papi, Chiara Milano, Laura Marmolejo, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 DiseaseYvette S Crijnen, Verena Endmayr, Suzanne C Franken, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
The Lancet. Neurology|March 21, 2026
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort studyMar Guasp, Mateus Mistieri Simabukuro, Guillermo Muñoz-Sánchez, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.
Pageof 5